Study to Evaluate Romosozumab in Children and Adolescents With Osteogenesis Imperfecta

Summary

The primary objective of this study is to evaluate the pharmacokinetics (PK) profile following multiple subcutaneous (SC) doses of romosozumab in children and adolescents with Osteogenesis Imperfecta (OI).

Timeline

Start

2021-01-21

Primary completion

2023-03-30

Completion

2023-03-30

Publications

• Tabaie SA, O'Mara AE, Sheppard ED, Tosi LL. A Comprehensive Review of Bone Health in a Child: From Birth to Adulthood. J Am Acad Orthop Surg. 2024 May 1;32(9):363-372. doi: 10.5435/JAAOS-D-23-00853. Epub 2024 Jan 23.

Drugs

Indications